Unibest
← Back to patent-cliff list

Enarodustat

Tier C — Watch / trade

Enarodustat

-
Originator
2020
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:HIF-PHs

Brand:エナロイ, Enaroy

Indications (approved):Chronic renal impairment, Anaemia

Regional status

US
No progress
2013-05-01
EU
-
China
Approved
2023-06-07
Japan
Approved
2020-09-25

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 11 · Total yield 2.16 g (Enarodustat)
ENARO-001262423-77-8ENARO-0021151655-02-5ENARO-0031262132-92-2ENARO-0041262132-93-3ENARO-0051262132-94-4ENARO-0061262132-95-5ENARO-0071262132-96-6ENARO-0081262132-97-7ENARO-009536-74-3ENARO-0101262133-02-7ENARO-0111262133-04-9ENARO-012623-33-6ENARO-0131262133-05-0ENARO-0141262133-06-1Enarodustat1262132-81-9API · Enarodustat
CodeCAS No.Intermediate
ENARO-001262423-77-82,4-dichloronicotinic acid
ENARO-0021151655-02-5tert-butyl 5-methylpyrazine-2-carboxylate
ENARO-0031262132-92-2tert-butyl 2,4-dichloronicotinate
ENARO-0041262132-93-3tert-butyl 4-(benzyloxy)-2-chloronicotinate
ENARO-0051262132-94-4tert-butyl 4-(benzyloxy)-2-hydrazinylnicotinate
ENARO-0061262132-95-5tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate
ENARO-0071262132-96-6tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate
ENARO-0081262132-97-7tert-butyl 7-(benzyloxy)-5-iodo-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate
ENARO-009536-74-3ethynylbenzene
ENARO-0101262133-02-7tert-butyl 7-(benzyloxy)-5-(phenylethynyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate
ENARO-0111262133-04-97-(benzyloxy)-5-(phenylethynyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylic acid compound with methanesulfonic acid (1:1)
ENARO-012623-33-6ethyl glycinate hydrochloride
ENARO-0131262133-05-0ethyl (7-(benzyloxy)-5-(phenylethynyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycinate
ENARO-0141262133-06-1ethyl (7-hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycinate
Enarodustat1262132-81-9-

Frequently asked questions

What are the approved indications of Enarodustat?

Approved indications include: Chronic renal impairment, Anaemia.

When does the Enarodustat patent expire?

No public expiry year is available for Enarodustat yet; this page updates once verified.

How many synthesis routes are recorded for Enarodustat?

1 synthesis routes are recorded; the shortest is 11 steps with 2.16 g (Enarodustat) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Enarodustat intermediates?

All intermediates in Enarodustat routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Enarodustat intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27